REVENUES - Percentage by Customer (Details) - Sales - Customer Concentration Risk |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
McKesson Corporation | ||||
Disaggregation of Revenue [Line Items] | ||||
Percentage | 31.00% | 49.00% | 35.00% | 46.00% |
Cencora Inc. | ||||
Disaggregation of Revenue [Line Items] | ||||
Percentage | 12.00% | 20.00% | 15.00% | 21.00% |
Cardinal Health Inc. | ||||
Disaggregation of Revenue [Line Items] | ||||
Percentage | 21.00% | 22.00% | ||
Lilly | ||||
Disaggregation of Revenue [Line Items] | ||||
Percentage | 39.00% | 26.00% |
X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|